VT-1: Began Clinical Testing

Select Therapeutics Inc. (SLPU), Cambridge, Mass. Product: VT-1 Business: Cancer Therapeutic category: Adjunct Target: Tumor cells in autologous stem cell transplants Description: Toxin that selective...